Home / Resource Library / Impact of Prior Bendamustine Exposure on Chimeric Antigen Receptor T-Cell Therapy Outcomes in Follicular Lymphoma

Impact of Prior Bendamustine Exposure on Chimeric Antigen Receptor T-Cell Therapy Outcomes in Follicular Lymphoma

Study examined the impact of prior bendamustine treatment in patients with follicular lymphoma receiving CAR-T therapy.